Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 23 Neoplasms 12 Lymphoma 4 Unspecified Adult Solid Tumor, Protocol Specific 3 Solid Tumors 2 Recurrence 2 Neuroblastoma 2 Neoplasm Metastasis 2 Lymphoma, Non-Hodgkin 2 Glioma 2 Glioblastoma 2 Brain Neoplasms 2 Thromboembolism 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Melanoma 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Follicular 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Hematologic Diseases 1 Granulosa Cell Tumor 1 Genetic Diseases, Inborn 1 Castration-resistant Prostate Cancer 1 Carcinoma 1 Breast Neoplasms 1 Astrocytoma 1 Advanced Cancer 1

Interventions

orteronel 1 Nivolumab 1 Ketoconazole 1 BID protein, human 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Granulosa Cell Tumor × Ketoconazole × Clear all

NCT01584297 2015-01-21

GreKo

Grupo Español de Tumores Huérfanos e Infrecuentes

Phase 2 Terminated

Granulosa Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡